Celcuity Inc (NAS:CELC)
$ 16.66 0.73 (4.58%) Market Cap: 584.78 Mil Enterprise Value: 418.73 Mil PE Ratio: 0 PB Ratio: 3.83 GF Score: 29/100

Celcuity Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 05:30PM GMT
Release Date Price: $10.1 (-1.03%)
Gil Blum
Needham & Company, LLC - Analyst

Thank you for joining me in the third day of the Needham & Company healthcare conference. My name is Gil Blum, and I'm a senior biotech analyst here at Needham & Company. It is my pleasure to have with me today, Brian Sullivan, the Chairperson and CEO of Celcuity.

As a reminder, any viewers who are watching through our conference portal are able to submit questions via the ask-a-question box below the video feed window. And with that, Brian, you have the floor.

Brian Sullivan
Celcuity Inc. - CEO & Co-Founder

Great. Well, thank you, Gil. And thank you, all, for attending the conference and attending this presentation. What I'd like to do is just give you a little background on the company and how we got into drug development business and then review data and the study design of an ongoing Phase 3 study that we have.

Well, I started the company about 10 years ago with our Chief Science Officer, with the goal of developing a new cellular analysis platform. Essentially, we had developed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot